Pyxis Oncology, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 16.15M
Gross Profit 15.67M
Operating items
Amortization - Intangibles 4.79M6.11M
Research & Development 49.59M58.75M
Selling, General & Administrative 32.61M25.42M
Other Operating Expenses 97.80M21.44M
Operating Expenses 82.20M105.61M
Operating Income -82.20M-89.46M
EBIT -82.20M-89.46M
Non-operating items
Non Operating Investment Income 0.06M0.11M
Interest & Investment Income 6.63M7.04M
Non Operating Income 8.41M9.96M
Net income details
EBT -73.79M-79.50M
Tax Provisions 0.10M-2.16M
Profit After Tax -73.80M-77.33M
Income from Continuing Operations -73.89M-77.33M
Consolidated Net Income -73.89M-77.33M
Income towards Parent Company -73.89M-77.33M
Net Income towards Common Stockholders -73.89M-77.33M
Additional items
EPS (Basic) -0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 30.57M32.76M35.10M58.13M59.47M
Shares Outstanding (Diluted Average) 58.45M
EBITDA -73.73M-77.22M
Shares Outstanding 59.97M
Tax Rate 0.00M